Collegium Pharmaceutical (COLL) Long-Term Debt Repayments (2016 - 2025)
Historic Long-Term Debt Repayments for Collegium Pharmaceutical (COLL) over the last 8 years, with Q3 2025 value amounting to $16.1 million.
- Collegium Pharmaceutical's Long-Term Debt Repayments changed N/A to $16.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.6 million, marking a year-over-year decrease of 4409.72%. This contributed to the annual value of $107.8 million for FY2024, which is 3365.35% down from last year.
- Per Collegium Pharmaceutical's latest filing, its Long-Term Debt Repayments stood at $16.1 million for Q3 2025.
- Collegium Pharmaceutical's 5-year Long-Term Debt Repayments high stood at $138.6 million for Q1 2023, and its period low was $12.5 million during Q1 2021.
- Over the past 5 years, Collegium Pharmaceutical's median Long-Term Debt Repayments value was $16.1 million (recorded in 2024), while the average stood at $29.9 million.
- Per our database at Business Quant, Collegium Pharmaceutical's Long-Term Debt Repayments skyrocketed by 115000.0% in 2021 and then tumbled by 6694.05% in 2024.
- Collegium Pharmaceutical's Long-Term Debt Repayments (Quarter) stood at $12.5 million in 2021, then surged by 100.0% to $25.0 million in 2022, then fell by 4.55% to $23.9 million in 2023, then crashed by 32.34% to $16.1 million in 2024, then changed by 0.0% to $16.1 million in 2025.
- Its Long-Term Debt Repayments stands at $16.1 million for Q3 2025, versus $16.1 million for Q2 2025 and $16.1 million for Q1 2025.